Bectas Therapeutics, Inc.

Form D Filings

Location
Houston, TX
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0002038826
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
10/8/2025 Equity $1,400,000 $5,550,000 $10,000,000 $4,450,000 10/21/2022 10/8/2025 D/A 000203882625000002
10/9/2024 Equity $4,150,000 $4,150,000 $10,000,000 $5,850,000 10/21/2022 10/9/2024 D 000203882624000001